Share This Page
Suppliers and packagers for GLIPIZIDE AND METFORMIN HYDROCHLORIDE
✉ Email this page to a colleague
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Heritage | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078728 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-115-01 | 100 TABLET, FILM COATED in 1 BOTTLE (23155-115-01) | 2010-06-29 |
| Heritage | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078728 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-115-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (23155-115-10) | 2010-06-29 |
| Heritage | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078728 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-116-01 | 100 TABLET, FILM COATED in 1 BOTTLE (23155-116-01) | 2010-06-29 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drugs: Glipizide and Metformin Hydrochloride
Introduction
The global demand for antidiabetic medications has surged due to the rising prevalence of type 2 diabetes mellitus worldwide. Among the cornerstone therapies are Glipizide and Metformin Hydrochloride, which are extensively prescribed for managing blood glucose levels. Identifying reliable suppliers for these agents is essential for pharmaceutical companies, health organizations, and policymakers aiming to ensure drug availability, quality, and cost-effectiveness. This article offers a comprehensive overview of primary suppliers involved in the production and distribution of Glipizide and Metformin Hydrochloride, emphasizing their manufacturing footprint, supply capabilities, regulatory status, and market dynamics.
Overview of Glipizide and Metformin Hydrochloride
Glipizide is a second-generation sulfonylurea that stimulates insulin secretion from pancreatic beta cells, thereby reducing blood glucose levels (1). Metformin Hydrochloride is a biguanide that decreases hepatic glucose production and enhances insulin sensitivity (2). Both drugs are often combined in fixed-dose formulations to improve therapeutic efficacy and patient compliance.
The widespread use of these drugs has created a robust demand chain comprising active pharmaceutical ingredient (API) producers, formulation manufacturers, and distributors globally.
Leading API Suppliers for Glipizide
1. Hikma Pharmaceuticals
Hikma Pharmaceuticals, based in Jordan, is a notable supplier of Glipizide API. The company's API manufacturing facilities adhere to stringent quality standards, including Good Manufacturing Practices (GMP). Hikra supplies APIs to multiple generic drug manufacturers across Europe, Asia, and the Middle East.
2. Zhejiang Hengkang Pharmaceutical
A leading Chinese API producer, Zhejiang Hengkang has significant capacity for Glipizide API. Their manufacturing plants are WHO-GMP certified, and they serve both domestic and export markets. China's dominance in generic API production underpins their role as key suppliers in this segment.
3. Wockhardt Limited
India-based Wockhardt manufactures Glipizide API with a presence in multiple regulatory markets. Their facilities are ISO, GMP, and US FDA compliant, offering high-quality APIs for generic formulations worldwide.
Leading API Suppliers for Metformin Hydrochloride
1. Cadila Healthcare
Cadila Healthcare (Zydus Cadila), India’s prominent pharmaceutical company, supplies high-quality Metformin API. Their manufacturing facilities meet global standards like US FDA, European EMA, and WHO-GMP. They’re recognized for their large-scale production capacity and cost-efficient supply chain.
2. Hetero Labs
Hetero Labs, another Indian giant, is a key player in Metformin Hydrochloride API production. Their APIs are used globally, and Hetero maintains a robust regulatory track record, enabling market access in the US, Europe, and emerging markets.
3. Teva Pharmaceutical Industries
Israel-based Teva is a global leader in generic APIs, including Metformin Hydrochloride. They emphasize innovation, quality, and scale to meet worldwide demand, with several manufacturing facilities compliant with international GMP standards.
4. Jiangsu Hengrui Medicine Co., Ltd.
A significant Chinese pharmaceutical company, Hengrui supplies Metformin API designed for both domestic and export purposes. Their large-scale manufacturing and strict quality controls position them as a reliable supplier in Asia and beyond.
Distribution and Market Dynamics
The supply chains for Glipizide and Metformin are deeply integrated with global generic pharmaceutical markets. India and China are dominant API producers, accounting cumulatively for over 70% of the world’s API output (3). The competitive landscape is characterized by capacity expansion, technological innovation, and regulatory compliance enhancements aiming to meet strict international standards.
Regulatory considerations significantly influence supplier selection. Manufacturers must demonstrate compliance with US FDA, EMA, or WHO-GMP standards to access high-growth markets. This compliance fosters supplier credibility and ensures drug safety and efficacy.
Furthermore, geopolitical tensions and trade policies impact supply stability. Recent disruptions, such as the COVID-19 pandemic, exposed vulnerabilities in supply chains, prompting pharmaceutical companies to diversify supplier sources and establish regional manufacturing hubs.
Quality and Regulatory Standards
The reliability of suppliers hinges on adherence to recognized standards:
- Good Manufacturing Practices (GMP) for APIs
- US FDA approval for facilities supplying the US market
- European EMA certification for compliance in EU markets
- WHO-GMP certification for broader international access
Ensuring suppliers meet these standards mitigates risks associated with substandard APIs, such as adverse reactions, regulatory sanctions, or product recalls.
Emerging Trends and Market Opportunities
The increasing focus on affordable generics has spurred capacity expansions in India and China. Moreover, technological advances like continuous manufacturing and quality by design (QbD) improve API quality and process efficiency.
There is also growing interest from Western pharmaceutical firms in partnering with Asian API producers to leverage cost advantages while maintaining compliance with regulatory standards.
Additionally, supply chain resilience is a priority, with companies investing in multi-source strategies and regional manufacturing to mitigate risks associated with geopolitical instability and global health crises.
Conclusion
The global supply landscape for Glipizide and Metformin Hydrochloride is dominated by established API manufacturers primarily in India and China, supported by a network of formulation and distribution partners worldwide. Trustworthy suppliers demonstrate strong regulatory compliance, substantial manufacturing capacity, and consistent quality standards.
As the demand for cost-effective, high-quality antidiabetic medications persists, continuous monitoring of supplier capacity expansions, regulatory developments, and geopolitical factors is essential for stakeholders to ensure uninterrupted supply and compliance integrity.
Key Takeaways
- Indian and Chinese API manufacturers are primary global suppliers of Glipizide and Metformin Hydrochloride, commanding substantial market shares owing to capacity and cost-effectiveness.
- Regulatory compliance with GMP, US FDA, and EMA standards is crucial for market access and risk mitigation.
- The industry is witnessing capacity expansion, technological innovation, and strategic diversification to bolster supply resilience.
- Geopolitical factors influence supplier stability; diversification remains key for ensuring continuous supply.
- Upstream API quality directly impacts drug safety, efficacy, and regulatory approval of finished pharmaceutical products.
FAQs
1. Which countries are the top suppliers of Glipizide and Metformin Hydrochloride APIs?
India and China lead API production for both drugs, accounting for a significant majority of global supply due to their manufacturing scale, technological capacity, and cost advantages.
2. How does regulatory compliance influence supplier selection?
Regulatory standards such as US FDA, EMA, and WHO-GMP certifications affirm API quality and safety, indispensable for market approval and partnership credibility.
3. Are there regional API manufacturing hubs emerging globally?
While India and China dominate, regions like Eastern Europe, Southeast Asia, and Latin America are developing capabilities to diversify supply chains and reduce geopolitical risks.
4. What are the main challenges facing API suppliers for these drugs?
Capacity constraints, regulatory compliance requirements, raw material sourcing, and geopolitical uncertainties pose ongoing challenges.
5. How can pharmaceutical companies ensure a stable supply of these APIs?
By establishing multi-source relationships, investing in regional manufacturing, and monitoring regulatory developments, companies can enhance supply resilience.
References
[1] American Diabetes Association, Standards of Medical Care in Diabetes 2022.
[2] Rena et al., “Metformin: An Old Drug for the Treatment of Diabetes and Possible New Applications,” Diabetes Care, 2016.
[3] G. Johnson, "Global API Market Analysis," Pharmaceutical Technology Review, 2021.
More… ↓
